Skip to content

Polaryx Therapeutics, Inc. PLYX Balance Sheet Statement

Q1 '26Q4 '25Q1 '25Q4 '24Q3 '24
$3.08M-40.1%$5.14M+1,957%$250K-94.6%$4.62M
$3.5M-32.3%$5.17M$5M
$3.5M-32.3%$5.17M$5M
$850K+80.9%$470K+2,865%-$17K-124%$72K+172%-$100.25K0.0%
$1.01M+67.6%$605K$289K
$1.01M+67.6%$605K$289K
$560M$560M
-$102.18M-2.6%-$99.64M-$90.65M
$2.49M-45.5%$4.57M+7.3%$4.25M-9.7%$4.71M
$3.5M-32.3%$5.17M$5M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Polaryx Therapeutics, Inc. 's total assets?
Polaryx Therapeutics, Inc. (PLYX) holds $3.5M in total assets.
How much cash does Polaryx Therapeutics, Inc. have?
Polaryx Therapeutics, Inc. holds $3.1M in cash and equivalents.
Can Polaryx Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 3.45 — current assets exceed current liabilities.
Where does Polaryx Therapeutics, Inc. 's balance sheet data come from?
Every line is extracted from Polaryx Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.